California State Teachers Retirement System (CalSTRS)’s Acrivon Therapeutics ACRV Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio ACRV Stock Details ACRV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-856	Closed	-$1.74K	–	2961
2025 Q1	$1.74K	Hold	856	–	–	﹤0.01%	3024
2024 Q4	$5.15K	Hold	856	–	–	﹤0.01%	2991
2024 Q3	$5.99K	Hold	856	–	–	﹤0.01%	2987
2024 Q2	$4.96K	Sell	856 -371	-30%	-$2.99K	﹤0.01%	3028
2024 Q1	$8.77K	Sell	1,227 -204	-14%	-$947	﹤0.01%	2934
2023 Q4	$7.04K	Sell	1,431 -487	-25%	-$2.57K	﹤0.01%	3029
2023 Q3	$18.3K	Sell	1,918 -973	-34%	-$11.2K	﹤0.01%	2994
2023 Q2	$37.5K	Sell	2,891 -327	-10%	-$3.96K	﹤0.01%	3001
2023 Q1	$40.8K	Buy	+3,218	New	+$54K	﹤0.01%	2880

Other funds holding ACRV

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

SCV

Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s ACRV Position: Q2 2025 in Review

California State Teachers Retirement System (CalSTRS) sold out of Acrivon Therapeutics (ACRV) in Q2 2025, closing a stake of 856 shares — an estimated $1.74K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in ACRV in Q1 2023 and held it in 9 quarters. The position peaked at $40.8K in Q1 2023. 53 funds tracked by Wall St. Rank hold ACRV as of Q2 2025.

California State Teachers Retirement System (CalSTRS) reported no remaining Acrivon Therapeutics position as of Q2 2025 after selling out during the quarter.
California State Teachers Retirement System (CalSTRS) sold 856 Acrivon Therapeutics shares in Q2 2025, an estimated $1.74K.
California State Teachers Retirement System (CalSTRS) first reported a position in Acrivon Therapeutics in Q1 2023 and held it in 9 quarters.
California State Teachers Retirement System (CalSTRS)'s Acrivon Therapeutics position peaked at $40.8K in Q1 2023.
53 funds tracked by Wall St. Rank held Acrivon Therapeutics as of Q2 2025.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2025, filed 14 Aug 2025.